284 related articles for article (PubMed ID: 22871739)
1. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.
Alla V; Kowtharapu BS; Engelmann D; Emmrich S; Schmitz U; Steder M; Pützer BM
Cell Cycle; 2012 Aug; 11(16):3067-78. PubMed ID: 22871739
[TBL] [Abstract][Full Text] [Related]
2. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
Vera J; Schmitz U; Lai X; Engelmann D; Khan FM; Wolkenhauer O; Pützer BM
Cancer Res; 2013 Jun; 73(12):3511-24. PubMed ID: 23447575
[TBL] [Abstract][Full Text] [Related]
3. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
Ray RM; Bhattacharya S; Johnson LR
Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
[TBL] [Abstract][Full Text] [Related]
4. GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria.
John K; Alla V; Meier C; Pützer BM
Cell Death Differ; 2011 May; 18(5):874-86. PubMed ID: 21127500
[TBL] [Abstract][Full Text] [Related]
5. p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem-like Features via miR-885-5p Control.
Meier C; Hardtstock P; Joost S; Alla V; Pützer BM
Cancer Res; 2016 Jan; 76(2):197-205. PubMed ID: 26554827
[TBL] [Abstract][Full Text] [Related]
6. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
8. Camptothecin induces p53-dependent and -independent apoptogenic signaling in melanoma cells.
Rudolf E; Rudolf K; Cervinka M
Apoptosis; 2011 Nov; 16(11):1165-76. PubMed ID: 21809047
[TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of E2F1 promotes proteolytic degradation of tumor suppressor p73 and inhibits its transcriptional activity.
Ozaki T; Okoshi R; Ono S; Kubo N; Nakagawara A
Biochem Biophys Res Commun; 2009 Sep; 387(1):143-8. PubMed ID: 19576172
[TBL] [Abstract][Full Text] [Related]
10. DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signaling.
Steder M; Alla V; Meier C; Spitschak A; Pahnke J; Fürst K; Kowtharapu BS; Engelmann D; Petigk J; Egberts F; Schäd-Trcka SG; Gross G; Nettelbeck DM; Niemetz A; Pützer BM
Cancer Cell; 2013 Oct; 24(4):512-27. PubMed ID: 24135282
[TBL] [Abstract][Full Text] [Related]
11. NEDDylation controls the target specificity of E2F1 and apoptosis induction.
Aoki I; Higuchi M; Gotoh Y
Oncogene; 2013 Aug; 32(34):3954-64. PubMed ID: 23001041
[TBL] [Abstract][Full Text] [Related]
12. Suppression of acetylpolyamine oxidase by selected AP-1 members regulates DNp73 abundance: mechanistic insights for overcoming DNp73-mediated resistance to chemotherapeutic drugs.
Bunjobpol W; Dulloo I; Igarashi K; Concin N; Matsuo K; Sabapathy K
Cell Death Differ; 2014 Aug; 21(8):1240-9. PubMed ID: 24722210
[TBL] [Abstract][Full Text] [Related]
13. p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.
Tophkhane C; Yang SH; Jiang Y; Ma Z; Subramaniam D; Anant S; Yogosawa S; Sakai T; Liu WG; Edgerton S; Thor A; Yang X
PLoS One; 2012; 7(8):e43564. PubMed ID: 22952705
[TBL] [Abstract][Full Text] [Related]
14. E1A activates transcription of p73 and Noxa to induce apoptosis.
Flinterman M; Guelen L; Ezzati-Nik S; Killick R; Melino G; Tominaga K; Mymryk JS; Gäken J; Tavassoli M
J Biol Chem; 2005 Feb; 280(7):5945-59. PubMed ID: 15572378
[TBL] [Abstract][Full Text] [Related]
15. Targeting p73--a potential approach in cancer treatment.
Slade N; Horvat A
Curr Pharm Des; 2011; 17(6):591-602. PubMed ID: 21391909
[TBL] [Abstract][Full Text] [Related]
16. TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity.
Chen D; Ming L; Zou F; Peng Y; Van Houten B; Yu J; Zhang L
Oncotarget; 2014 Sep; 5(18):8107-22. PubMed ID: 25237903
[TBL] [Abstract][Full Text] [Related]
17. Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21waf1/cip1 among human bronchogenic carcinomas.
Harr MW; Graves TG; Crawford EL; Warner KA; Reed CA; Willey JC
Mol Cancer; 2005 Jul; 4():23. PubMed ID: 16014176
[TBL] [Abstract][Full Text] [Related]
18. α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73.
Tiwary R; Yu W; Sanders BG; Kline K
Breast Cancer Res; 2011 Jan; 13(1):R1. PubMed ID: 21214929
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-361-3p promotes human breast cancer cell viability by inhibiting the E2F1/P73 signalling pathway.
Hua B; Li Y; Yang X; Niu X; Zhao Y; Zhu X
Biomed Pharmacother; 2020 May; 125():109994. PubMed ID: 32092817
[TBL] [Abstract][Full Text] [Related]
20. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.
Ory B; Ramsey MR; Wilson C; Vadysirisack DD; Forster N; Rocco JW; Rothenberg SM; Ellisen LW
J Clin Invest; 2011 Feb; 121(2):809-20. PubMed ID: 21293058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]